我们是否了解未得到满足的需求? 建议使用寿命等价值 (LOLE) 作为未满足需求的以患者为中心的衡量标准
Kevin Marsh1, Robert F Reynolds2,3, Linda Nelsen4
1Evidera, London, UK. kevin.marsh@thermofisher.com.
PharmacoEconomics - open
|February 17, 2025
概括
这项研究提出了一种新的定量衡量标准,即寿命相当值 (LOLE),用于使用患者体验数据评估未满足的医疗需求. LOLE的目标是提供一种标准化,以患者为中心的方法来评估疾病的影响,而不仅仅是生活质量.
科学领域:
- 卫生经济学 卫生经济学
- 患者报告的结果
- 决策分析 决策分析
背景情况:
- 决策者强调患者经验数据,以衡量未满足的需求.
- 目前的未满足需求措施缺乏标准化和以患者为中心的方法.
- 患者偏好数据对于评估未满足需求至关重要.
研究的目的:
- 提出一个标准化的,以患者为中心的,无病的,量化未满足需求的测量方法.
- 引入寿命相当值 (LOLE) 作为一种新型指标.
- 为了解决捕获疾病影响的现有方法的局限性.
主要方法:
- 审查决策者对未满足需求的定义.
- 提出一个量化估计的值方法.
- 开发寿命等效 (LOLE) 的指标.
主要成果:
- LOLE提供了一个标准化的,以患者为中心的,对未满足需求的定量估计.
- LOLE可以捕捉疾病的影响,而不仅仅是与健康相关的生活质量.
- LOLE对患者报告的疾病影响可能更敏感.
结论:
- LOLE提供了一种有前途的方法来衡量未满足的需求.
- 需要进一步的研究来解决LOLE的可接受性和整合问题.
- 关于LOLE的指标,估计和应用的关键决策者问题需要进一步调查.
相关概念视频
Kaplan-Meier Approach
79
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
79
Actuarial Approach
54
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
54
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Introduction To Survival Analysis
162
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
162
Assumptions of Survival Analysis
84
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
84
Noncompartmental Analysis: Mean Residence Time
93
According to statistical moment theory, mean residence time (MRT) is an important measure in pharmacokinetics. MRT can be defined as the expected mean of a probability density function distribution. It provides valuable insights into drug disposition in the body.
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
93


